Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval.
Hoeh B, Preisser F, Zattoni F, Kretschmer A, Westhofen T, Olivier J, Soeterik TFW, van den Bergh RCN, Mandel P, Graefen M, Tilki D; EAU-YAU Prostate Cancer Working Group. Hoeh B, et al. Eur Urol Oncol. 2024 Sep 20:S2588-9311(24)00194-9. doi: 10.1016/j.euo.2024.08.008. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39306583
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis.
Wenzel M, Cano Garcia C, Humke C, Hoeh B, Steuber T, Tilki D, Merseburger AS, Kluth LA, Chun FKH, Mandel P. Wenzel M, et al. Among authors: hoeh b. Eur Urol Oncol. 2024 Aug 31:S2588-9311(24)00192-5. doi: 10.1016/j.euo.2024.08.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39218743 Free article.
Epigenetic profiling of prostate cancer reveals potential prognostic signatures.
Bernatz S, Reddin IG, Fenton TR, Vogl TJ, Wild PJ, Köllermann J, Mandel P, Wenzel M, Hoeh B, Mahmoudi S, Koch V, Grünewald LD, Hammerstingl R, Döring C, Harter PN, Weber KJ. Bernatz S, et al. Among authors: hoeh b. J Cancer Res Clin Oncol. 2024 Aug 24;150(8):396. doi: 10.1007/s00432-024-05921-0. J Cancer Res Clin Oncol. 2024. PMID: 39180680 Free PMC article.
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy.
Chierigo F, Flammia RS, Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Montorsi F, Chun FKH, Shariat SF, Antonelli A, Guano G, Mantica G, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: hoeh b. Curr Urol. 2024 Jun;18(2):128-132. doi: 10.1097/CU9.0000000000000188. Epub 2024 Jun 21. Curr Urol. 2024. PMID: 39176293 Free PMC article.
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients.
Wenzel M, Lutz M, Hoeh B, Koll F, Cano Garcia C, Siech C, Steuber T, Graefen M, Tilki D, Kluth LA, Banek S, Chun FKH, Mandel P. Wenzel M, et al. Among authors: hoeh b. Clin Genitourin Cancer. 2024 Oct;22(5):102158. doi: 10.1016/j.clgc.2024.102158. Epub 2024 Jul 10. Clin Genitourin Cancer. 2024. PMID: 39106561 Free article.
Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer.
Wenzel M, Hoeh B, Kopf P, Siech C, Humke C, Würnschimmel C, Steuber T, Graefen M, Preisser F, Traumann M, Banek S, Kluth LA, Chun FK, Mandel P. Wenzel M, et al. Among authors: hoeh b. Urol Oncol. 2024 Nov;42(11):371.e11-371.e18. doi: 10.1016/j.urolonc.2024.06.016. Epub 2024 Aug 3. Urol Oncol. 2024. PMID: 39098477 Free article.
112 results